EXEL Stock Balance Sheets

Exelixis Quarterly Balance Sheets Chart

Quarterly

Annual

Goodwill

Cash and Cash Eq

Account Payables

Inventory

Exelixis Quarterly Balance Sheets Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-09-30	2003-06-30

assets
current assets:
cash and cash equivalents	164,433,000	183,752,000	217,374,000	258,346,000	198,459,000	259,561,000	262,994,000	396,859,000	464,480,000	540,597,000	501,195,000	675,286,000	627,000,000	723,269,000	647,169,000	567,325,000	492,462,000	370,209,000	319,217,000	334,046,000	527,143,000	357,340,000	266,501,000	242,317,000	369,789,000	373,937,000	314,775,000	353,623,000	248,407,000	232,331,000	183,164,000	149,357,000	135,212,000	183,179,000	151,686,000	111,219,000	129,827,000	276,882,000	141,634,000	145,642,000	61,949,000	84,987,000	80,395,000	100,065,000	147,340,000	157,539,000	103,978,000	92,016,000	131,774,000	171,232,000	170,069,000	308,805,000	68,140,000	70,466,000	74,257,000	66,211,000	75,280,000	202,051,000	97,440,000	95,342,000	157,202,000	58,292,000	86,796,000	170,570,000	152,912,000	201,425,000	247,698,000	64,230,000	75,047,000	121,883,000	135,457,000	141,326,000	105,607,000	143,839,000	123,369,000	55,700,000	86,017,000	140,101,000	96,471,000	90,010,000	104,821,000	61,384,000	78,105,000	47,993,000	38,924,000	80,323,000	55,056,000	68,572,000
marketable securities	626,665,000	847,564,000	893,902,000	930,815,000																																																163,542,000	138,901,000	172,979,000	120,005,000	156,947,000	187,502,000	99,621,000	65,224,000	71,929,000	55,593,000	94,243,000	116,290,000	115,737,000	42,993,000	4,044,000		26,159,000	61,634,000	79,509,000	105,153,000	95,965,000	78,236,000	83,636,000	55,516,000	15,965,000	30,145,000	36,995,000	67,307,000
trade receivables	292,354,000	281,637,000	265,437,000	269,706,000	396,584,000	240,577,000	237,407,000	248,113,000	232,818,000	233,923,000	214,784,000	215,015,000	235,400,000	190,614,000	282,650,000	179,493,000	171,753,000	177,673,000	160,875,000	166,138,000	121,080,000	137,338,000	119,073,000	169,788,000	97,541,000	107,670,000	162,771,000
inventory	23,483,000	24,853,000	22,388,000	21,013,000	20,614,000	21,106,000	17,323,000	24,978,000	28,635,000	29,908,000	33,299,000	26,711,000	33,020,000	28,467,000	27,493,000	28,240,000	24,982,000	24,757,000	20,973,000	19,319,000	16,608,000	15,417,000	12,886,000	13,366,000	12,352,000	10,143,000	9,838,000	10,433,000	8,371,000	7,563,000	6,657,000	5,806,000	5,425,000	3,304,000	3,338,000	3,292,000	2,808,000	2,472,000	2,616,000	2,121,000	2,608,000	2,593,000	2,381,000	3,876,000	3,026,000	2,686,000	2,890,000	1,764,000	681,000	280,000
prepaid expenses and other current assets	73,829,000	58,696,000	68,478,000	69,838,000	58,247,000	67,490,000	67,926,000	66,891,000	62,259,000	60,654,000	62,211,000	52,903,000	48,281,000	53,333,000	57,530,000	51,564,000	49,878,000	46,341,000	57,011,000	34,470,000	43,937,000	29,773,000	26,988,000	14,490,000	12,847,000	14,146,000	15,017,000	12,279,000	10,327,000	6,850,000	8,750,000	8,012,000	4,433,000	6,297,000	5,416,000	7,148,000	4,657,000	4,791,000	3,806,000	3,949,000	2,731,000	5,212,000	3,481,000	7,860,000	4,792,000	5,386,000	5,112,000	7,799,000	5,880,000	11,030,000	6,104,000	6,098,000	4,498,000	4,641,000	4,372,000	17,062,000	14,555,000	16,766,000	14,926,000	17,635,000	16,025,000	18,000,000	15,050,000	10,621,000	8,882,000	8,453,000	7,713,000	6,760,000	8,201,000	7,689,000	6,151,000	9,755,000	9,478,000	6,997,000	6,082,000	7,502,000	6,152,000	4,951,000	5,442,000				4,350,000
total current assets	1,180,764,000	1,396,502,000	1,467,579,000	1,549,718,000	1,477,444,000	1,292,429,000	1,317,958,000	1,443,369,000	1,590,527,000	1,637,618,000	1,618,762,000	1,841,621,000	1,851,639,000	1,842,743,000	1,834,747,000	1,662,028,000	1,593,246,000	1,434,265,000	1,445,395,000	1,407,808,000	1,394,663,000	1,136,896,000	1,011,190,000	972,112,000	957,247,000	946,298,000	897,016,000	786,962,000	686,286,000	565,680,000	484,874,000	470,921,000	402,239,000	467,950,000	470,803,000	421,328,000	353,383,000	339,468,000	178,665,000	207,351,000	91,803,000	125,040,000	167,241,000	220,670,000	258,583,000	298,309,000	266,609,000	306,164,000	374,956,000	383,945,000	432,541,000	493,395,000	213,823,000	250,016,000	228,824,000	244,874,000	283,700,000	324,209,000	183,486,000	192,212,000	234,848,000	177,625,000	230,000,000	306,522,000	213,647,000	230,215,000	271,571,000	117,442,000	173,762,000	245,844,000	283,783,000	294,033,000	240,885,000	289,236,000	262,251,000	142,418,000	188,741,000	218,262,000	210,361,000	214,293,000	197,911,000	141,963,000	163,957,000	142,466,000	170,239,000	209,210,000	207,361,000	234,943,000
non-current marketable securities	594,652,000	619,441,000	637,291,000	523,421,000
property and equipment	110,314,000	115,030,000	119,391,000	124,414,000	130,210,000	127,222,000	128,731,000	121,039,000	115,004,000	116,212,000	110,624,000	107,909,000	108,529,000	106,169,000	104,031,000	99,838,000	95,133,000	78,453,000	67,384,000	56,385,000	52,323,000	48,489,000	48,892,000	49,467,000	50,709,000	50,553,000	50,897,000	51,046,000	64,744,000	45,412,000	25,743,000	19,256,000	18,684,000	2,594,000	2,071,000	1,737,000	1,982,000	1,813,000	1,434,000	1,448,000	1,812,000	2,158,000	2,432,000	2,928,000	4,052,000	4,685,000	4,910,000	5,520,000	5,650,000	5,786,000	6,059,000	6,292,000	6,439,000	7,326,000	8,506,000	10,196,000	11,903,000	13,605,000	15,811,000	18,776,000	20,923,000	24,379,000	29,392,000	28,481,000	30,696,000	33,354,000	36,247,000	38,683,000	39,417,000	35,825,000	34,664,000	36,266,000	34,621,000	32,451,000	32,294,000	33,344,000	33,769,000	33,715,000	35,577,000	36,144,000	36,965,000	36,065,000	35,463,000	33,795,000	33,794,000	32,077,000	34,622,000	35,282,000
deferred tax assets	419,241,000	419,045,000	420,027,000	358,869,000	361,561,000	361,578,000	361,145,000	230,990,000	231,115,000	229,603,000	231,110,000	116,415,000	113,958,000	98,001,000	111,663,000	125,295,000	134,667,000	160,598,000	156,711,000	155,678,000	148,235,000	163,187,000	172,374,000	186,836,000	210,237,000	243,717,000	244,111,000
goodwill	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	63,684,000	65,999,000	67,364,000	67,364,000	67,364,000	67,364,000	67,364,000	67,364,000	67,364,000	67,364,000	67,364,000	67,364,000	67,364,000	67,364,000	67,364,000	67,364,000	67,364,000	67,364,000
right-of-use assets and other non-current assets	309,426,000	223,545,000	239,718,000	340,170,000	307,917,000
total assets	2,678,081,000	2,837,247,000	2,947,690,000	2,960,276,000	2,773,121,000	2,803,752,000	2,942,357,000	2,976,910,000	3,142,468,000	3,143,359,000	3,071,489,000	2,961,372,000	2,881,404,000	2,654,118,000	2,616,239,000	2,447,741,000	2,367,271,000	2,190,542,000	2,137,333,000	2,111,043,000	2,046,548,000	1,955,604,000	1,885,670,000	1,784,865,000	1,643,098,000	1,541,794,000	1,422,286,000	1,024,366,000	911,158,000	774,915,000	655,294,000	609,772,000	516,532,000	586,980,000	597,541,000	548,490,000	477,136,000	492,533,000	332,342,000	363,241,000	248,778,000	282,934,000	327,960,000	383,656,000	440,635,000	497,565,000	503,287,000	555,959,000	612,084,000	659,527,000	721,097,000	762,613,000	374,488,000	412,600,000	393,262,000	411,636,000	454,182,000	495,736,000	360,790,000	372,906,000	419,725,000	284,220,000	343,410,000	421,102,000	333,177,000	355,105,000	401,622,000	254,763,000	316,621,000	370,572,000	412,120,000	420,291,000	371,788,000	420,631,000	395,417,000	270,657,000	306,477,000	337,582,000	332,712,000	338,706,000	325,145,000	269,753,000	291,340,000	267,869,000	287,193,000	321,657,000	336,824,000	359,230,000
liabilities and stockholders’ equity
current liabilities:
accounts payable	25,821,000	42,840,000	38,191,000	59,309,000	28,676,000	26,069,000	33,768,000	26,450,000	25,994,000	32,621,000	32,667,000	30,572,000	19,978,000	17,285,000	24,258,000	24,314,000	20,450,000	13,821,000	23,632,000	47,927,000	9,103,000	15,321,000	11,581,000	8,352,000	12,274,000	9,748,000	10,901,000	8,679,000	13,023,000	11,078,000	9,575,000	5,988,000	7,037,000	4,649,000	6,565,000	3,965,000	5,435,000	5,657,000	6,401,000	2,256,000	3,398,000	1,303,000	6,413,000	3,362,000	4,638,000	4,943,000	9,345,000	3,559,000	3,458,000	3,498,000	4,398,000	3,246,000	2,931,000	1,878,000	1,957,000	3,390,000	2,298,000	2,945,000	2,046,000	2,906,000	3,343,000	3,577,000	7,403,000	4,048,000	7,904,000	4,570,000	4,946,000	7,342,000	6,928,000	9,198,000	9,288,000	5,041,000	5,004,000	5,433,000	3,699,000	2,755,000	3,095,000	3,120,000	1,689,000	2,065,000	3,565,000	2,204,000	5,931,000	1,622,000	1,811,000	2,938,000	1,592,000	3,304,000
accrued compensation and benefits	72,250,000	89,747,000	109,830,000	90,605,000	71,806,000	72,958,000	93,325,000	81,398,000	68,213,000	56,551,000	77,158,000	66,927,000	61,450,000	42,768,000	61,969,000	53,306,000	48,324,000	37,945,000	51,189,000	40,782,000	33,156,000	26,687,000	37,364,000	31,713,000	24,144,000	22,550,000	32,142,000	27,283,000	21,538,000	20,756,000	21,073,000	19,914,000	15,555,000	14,490,000	20,334,000	15,986,000	10,307,000	6,042,000	3,629,000	3,725,000	3,249,000	3,459,000	3,350,000	6,441,000	9,856,000	8,088,000	12,797,000	9,342,000	8,127,000	6,500,000	10,375,000	8,255,000	7,914,000	6,586,000	8,943,000	8,835,000	8,159,000	6,888,000	12,078,000	12,069,000	11,459,000	20,500,000	16,677,000	15,215,000	13,910,000	11,383,000	16,142,000	17,828,000	13,093,000	13,303,000	14,480,000	14,610,000	10,580,000	10,880,000	11,456,000	10,781,000	7,004,000	6,791,000	7,817,000	7,236,000	5,449,000	4,950,000	6,297,000	6,330,000	5,049,000	4,914,000	5,743,000	4,379,000
accrued clinical trial liabilities	57,874,000	57,635,000	57,976,000	56,184,000	64,829,000	59,337,000	71,615,000	62,842,000	59,260,000	64,210,000	65,072,000	62,057,000	76,740,000	82,885,000	77,544,000	70,618,000	67,075,000	59,762,000	52,251,000	47,074,000	39,940,000	34,969,000	38,777,000	30,330,000	23,709,000	23,055,000	18,231,000	18,958,000	16,801,000	15,351,000	19,849,000	16,181,000	14,680,000	14,478,000	14,131,000	14,887,000	15,681,000	16,135,000	18,071,000	29,788,000	32,572,000	30,976,000	41,545,000	45,102,000	41,367,000	39,118,000	34,958,000	35,042,000	29,406,000	21,263,000	20,560,000	23,701,000	23,982,000	21,634,000	21,729,000	24,957,000	28,761,000	31,681,000	30,975,000	30,060,000	29,200,000	27,713,000	24,000,000	18,982,000	15,140,000	20,752,000	22,551,000	26,674,000	25,280,000	24,101,000	21,651,000	19,554,000	17,811,000	15,866,000	12,209,000
rebates and fees due to customers	57,276,000	57,840,000	62,376,000	62,495,000	58,468,000	75,651,000	59,619,000	54,374,000	52,486,000	66,405,000	50,350,000	43,791,000	43,795,000	49,997,000	33,700,000	31,120,000	31,197,000	31,468,000	20,683,000	19,129,000	16,957,000	23,006,000	18,719,000	16,782,000	17,273,000	19,708,000	14,954,000	11,689,000	11,143,000	11,989,000	7,565,000
accrued collaboration liabilities	21,525,000	25,489,000	40,384,000	30,030,000	18,683,000	34,704,000	27,533,000	27,269,000	22,960,000	18,324,000	20,188,000	18,277,000	29,990,000	32,492,000	86,753,000	35,403,000	24,428,000	13,461,000	12,456,000	11,102,000	10,695,000	8,663,000	11,856,000	7,973,000	7,847,000	7,556,000	7,419,000	8,397,000	7,713,000	7,974,000	8,974,000	9,137,000	7,919,000
other current liabilities	101,365,000	125,551,000	95,012,000	95,723,000	103,241,000	104,291,000	108,417,000	124,483,000	110,704,000	89,486,000	78,924,000	80,109,000	72,568,000	63,652,000	53,366,000	54,747,000	63,852,000	56,880,000	44,447,000	35,329,000	32,830,000	31,831,000	24,449,000	45,919,000	25,228,000	40,139,000	21,825,000	15,900,000	23,787,000	17,711,000	16,150,000	26,356,000	21,225,000	24,659,000	20,771,000
total current liabilities	336,111,000	399,102,000	403,769,000	394,346,000	345,703,000	373,010,000	394,277,000	376,816,000	339,617,000	327,597,000	324,359,000	301,733,000	304,521,000	289,079,000	337,590,000	269,508,000	255,326,000	213,337,000	204,658,000	201,343,000	142,681,000	140,477,000	142,746,000	141,069,000	110,796,000	125,132,000	105,472,000	90,906,000	99,944,000	84,859,000	115,170,000	108,953,000	97,671,000	202,287,000	270,588,000	201,643,000	192,795,000	101,067,000	52,251,000	55,922,000	60,316,000	58,680,000	171,860,000	173,912,000	171,857,000	71,056,000	87,853,000	77,880,000	74,600,000	67,799,000	81,704,000	85,415,000	90,147,000	87,459,000	92,325,000	166,615,000	193,542,000	198,123,000	199,941,000	203,969,000	222,015,000	210,344,000	207,118,000	214,995,000	184,474,000	176,458,000	189,543,000	118,882,000	134,142,000	132,781,000	132,885,000	120,491,000	115,821,000	125,822,000	111,437,000	82,331,000	86,470,000	124,319,000	108,755,000	88,693,000	91,893,000	67,981,000	63,796,000	42,168,000	40,565,000	47,814,000	44,487,000	50,598,000
non-current operating lease liabilities	179,842,000	187,125,000	190,823,000
other non-current liabilities	128,592,000	119,996,000	108,895,000	96,066,000
total liabilities	644,545,000	706,223,000	703,487,000	684,857,000	653,387,000	675,744,000	678,445,000	629,290,000	614,530,000	588,223,000	583,062,000	469,970,000	490,144,000	360,267,000	405,624,000	335,294,000	324,194,000	279,355,000	258,220,000	259,012,000	213,224,000	207,952,000	199,700,000	181,148,000	154,466,000	156,774,000	134,833,000	108,400,000	136,190,000	105,149,000	370,333,000	371,057,000	368,021,000	467,230,000	508,223,000	516,468,000	663,270,000	648,487,000	436,646,000	437,469,000	436,966,000	429,693,000	442,789,000	442,167,000	437,392,000	426,083,000	437,049,000	423,196,000	415,752,000	404,675,000	424,663,000	421,768,000	275,439,000	280,251,000	302,630,000	408,582,000	535,997,000	564,485,000	589,115,000	590,499,000	634,419,000	483,505,000	507,135,000	563,872,000	456,796,000	444,053,000	457,883,000	278,211,000	304,563,000	321,178,000	326,609,000	319,657,000	327,982,000	351,160,000	304,806,000	245,321,000	255,013,000	303,060,000	275,417,000	254,158,000	262,931,000	236,645,000	240,669,000	187,202,000	180,077,000	187,010,000	153,373,000	158,766,000
commitments and contingencies
stockholders’ equity:
preferred stock, 0.001 par value, 10,000 shares authorized and no shares issued
common stock	270,000	275,000	282,000	286,000	285,000	295,000	303,000	311,000	320,000	325,000	324,000	323,000	322,000	320,000	319,000	316,000	315,000	313,000	312,000	309,000	309,000	306,000	305,000	304,000	303,000	302,000	300,000	299,000	298,000	297,000	296,000	296,000	294,000	292,000	290,000	286,000	230,000	228,000	228,000	225,000	196,000	196,000	196,000	195,000	195,000	194,000	184,000	184,000	184,000	184,000	183,000					129,000	128,000	127,000	109,000	109,000	109,000	108,000	108,000	107,000	107,000	106,000	106,000	106,000	105,000	105,000	105,000	104,000	97,000	97,000	96,000	84,000	85,000	85,000	84,000	84,000	77,000	76,000	75,000	73,000	73,000	72,000	72,000	71,000
additional paid-in-capital	2,251,456,000	2,292,033,000	2,343,915,000																																																	1,542,489,000	1,267,890,000	1,264,659,000	1,196,992,000	1,155,827,000	1,148,588,000	1,140,700,000	953,608,000	946,469,000	940,765,000	933,481,000	925,736,000	917,916,000	911,699,000	903,069,000	897,423,000	889,313,000	883,208,000	871,443,000	863,127,000	855,403,000	776,617,000	766,282,000	756,568,000	659,198,000	654,761,000	644,096,000	636,263,000	634,264,000	584,045,000	579,284,000	569,345,000	547,251,000	546,569,000	543,922,000	541,276,000	532,913,000
accumulated other comprehensive income	1,349,000	2,010,000		3,956,000											-758,000	1,481,000	1,985,000	2,740,000	4,476,000	6,239,000	7,840,000	-222,000	3,069,000	2,668,000	2,207,000	728,000											129,000						-121,000	24,000	177,000	153,000	146,000	180,000		102,000		-18,000	5,000	50,000	-138,000	-249,000	-13,000	-32,000	12,000	18,000	18,000	99,000	155,000	96,000	20,000	3,000		178,000	602,000	1,236,000	499,000	1,017,000	1,102,000	1,080,000	1,145,000	1,207,000	1,028,000	1,007,000	973,000	812,000	844,000	532,000	624,000	794,000	736,000	1,624,000	1,563,000	2,210,000
accumulated deficit	-219,539,000	-163,294,000	-98,647,000	-90,293,000	-199,972,000	-258,948,000	-173,351,000	-126,049,000			-34,225,000	-4,052,000	-77,262,000	-147,934,000	-216,507,000	-311,673,000	-349,877,000	-445,969,000	-447,570,000	-475,958,000	-443,918,000	-510,739,000	-559,351,000	-628,094,000	-725,546,000	-804,588,000	-880,363,000	-1,240,452,000	-1,367,316,000	-1,454,810,000	-1,829,172,000	-1,867,661,000	-1,949,043,000	-1,966,699,000	-1,983,147,000	-2,018,270,000	-2,035,403,000	-1,998,388,000	-1,937,041,000	-1,893,400,000	-1,845,836,000	-1,802,474,000	-1,767,304,000	-1,709,351,000	-1,646,791,000	-1,573,381,000	-1,498,762,000	-1,428,016,000	-1,360,892,000	-1,298,731,000	-1,254,002,000	-1,201,809,000	-1,168,995,000	-1,132,508,000	-1,106,357,000	-1,152,653,000	-1,230,518,000	-1,209,544,000	-1,182,054,000	-1,164,189,000	-1,155,586,000	-1,132,973,000	-1,089,724,000	-1,060,889,000	-1,035,445,000	-990,684,000	-954,504,000	-916,555,000	-878,048,000	-832,924,000	-791,650,000	-771,728,000	-758,032,000	-729,470,000	-705,269,000	-680,087,000	-654,890,000	-630,900,000	-603,777,000	-579,255,000	-556,481,000	-546,784,000	-519,373,000
total stockholders’ equity	2,033,536,000	2,131,024,000	2,244,203,000	2,275,419,000	2,119,734,000	2,128,008,000	2,263,912,000	2,347,620,000			2,488,427,000				2,210,615,000	2,112,447,000	2,043,077,000	1,911,187,000	1,879,113,000	1,852,031,000	1,833,324,000	1,747,652,000	1,685,970,000	1,603,717,000	1,488,632,000	1,385,020,000	1,287,453,000	915,966,000	774,968,000	669,766,000	284,961,000	238,715,000	148,511,000	119,750,000	89,318,000	32,022,000									3,243,000	71,482,000	66,238,000	132,763,000	196,332,000	254,852,000	296,434,000	340,845,000	99,049,000	132,349,000	90,632,000	3,054,000											-56,975,000	-26,958,000	5,867,000	39,860,000	72,081,000	84,796,000	19,784,000	37,989,000	52,540,000	-19,598,000	984,000	14,288,000	33,543,000	55,905,000	28,485,000	33,108,000	50,671,000	80,667,000	107,116,000	134,647,000	183,451,000	200,464,000
total liabilities and stockholders’ equity	2,678,081,000	2,837,247,000	2,947,690,000				2,942,357,000				3,071,489,000				2,616,239,000	2,447,741,000	2,367,271,000	2,190,542,000	2,137,333,000	2,111,043,000	2,046,548,000	1,955,604,000	1,885,670,000	1,784,865,000	1,643,098,000	1,541,794,000	1,422,286,000	1,024,366,000	911,158,000	774,915,000	655,294,000	609,772,000	516,532,000	586,980,000	597,541,000	548,490,000									440,635,000	497,565,000	503,287,000	555,959,000	612,084,000	659,527,000	721,097,000	762,613,000	374,488,000	412,600,000	393,262,000	411,636,000																								338,706,000	325,145,000	269,753,000	291,340,000	267,869,000	287,193,000	321,657,000	336,824,000	359,230,000
accumulated other comprehensive loss			-1,347,000		-5,149,000	-5,204,000	-3,750,000	-14,012,000	-14,437,000	-9,289,000	-14,521,000	-17,538,000	-8,917,000	-6,665,000													-701,000	-513,000	-731,000	-887,000	-347,000	-52,000	-119,000	-326,000	-416,000	-80,000		-42,000	-232,000	-41,000	-174,000	-61,000							-263,000		-92,000
non-current portion of operating lease liabilities				194,445,000
stockholders' equity:
additional paid-in capital				2,361,470,000	2,324,570,000	2,391,865,000	2,440,710,000	2,487,370,000	2,530,869,000	2,558,297,000	2,536,849,000	2,512,669,000	2,477,117,000	2,448,130,000	2,427,561,000	2,422,323,000	2,390,654,000	2,354,103,000	2,321,895,000	2,321,441,000	2,269,093,000	2,258,307,000	2,241,947,000	2,228,839,000	2,211,668,000	2,188,578,000	2,168,217,000	2,156,632,000	2,142,717,000	2,125,166,000	2,114,184,000	2,106,132,000	2,097,379,000	2,086,483,000	2,072,591,000	2,050,086,000	1,848,910,000	1,842,248,000	1,832,741,000	1,818,988,000	1,657,626,000	1,655,580,000	1,652,400,000	1,650,621,000	1,649,662,000	1,644,516,000	1,564,670,000	1,560,415,000	1,557,303,000	1,553,297,000	1,550,345,000
total liabilities and stockholders' equity				2,960,276,000	2,773,121,000	2,803,752,000		2,976,910,000	3,142,468,000	3,143,359,000		2,961,372,000	2,881,404,000	2,654,118,000
short-term investments					803,540,000	703,695,000	732,308,000	706,528,000	802,335,000	772,536,000	807,273,000	871,706,000	907,938,000	847,060,000	819,905,000	835,406,000	854,171,000	815,285,000	887,319,000	853,835,000	685,895,000	597,028,000	585,742,000	518,350,000	452,328,000	425,713,000	378,559,000	281,000,000	251,516,000	194,589,000	204,607,000	217,741,000	214,044,000	241,094,000	268,117,000	208,462,000	198,292,000	45,235,000	25,426,000	52,169,000	14,648,000	22,258,000	63,890,000	91,937,000	86,177,000	116,033,000	138,475,000	187,203,000	220,198,000	185,332,000	241,371,000																													72,929,000	42,682,000	62,189,000	77,078,000	82,851,000	123,722,000	121,551,000	144,627,000	156,774,000
long-term investments					432,305,000	629,561,000	728,717,000	811,680,000	838,615,000	806,615,000	756,731,000	551,735,000	463,889,000	404,535,000	371,112,000	362,218,000	345,613,000	328,860,000	332,306,000	358,079,000	327,141,000	486,036,000	536,385,000	486,763,000	337,785,000	218,619,000	157,187,000	114,093,000	94,396,000	96,710,000	64,255,000	50,569,000	26,413,000	47,351,000	55,601,000	55,817,000	51,727,000	82,850,000	83,600,000	81,600,000	81,598,000	81,597,000	81,579,000	84,589,000	95,513,000	111,155,000	144,299,000	157,402,000	138,125,000	176,088,000	182,311,000	162,173,000	83,678,000	84,470,000	85,260,000	85,787,000	86,574,000	85,825,000	87,314,000	87,295,000	89,422,000	9,502,000	11,463,000				17,769,000
long-term portion of operating lease liabilities					198,017,000	201,466,000	189,944,000	190,858,000	194,694,000	186,948,000	190,170,000	159,838,000	161,019,000	50,636,000	51,272,000	52,252,000	53,223,000	52,837,000	49,086,000	47,626,000	48,334,000	47,883,000	48,011,000
other long-term liabilities					109,667,000	101,268,000	94,224,000	61,616,000	73,495,000	67,379,000	61,951,000	1,908,000	17,395,000	12,517,000	8,023,000	4,090,000	7,068,000	3,421,000	721,000	721,000	7,206,000	5,459,000	2,347,000	975,000	4,495,000	3,361,000	1,286,000	2,607,000	3,630,000	17,113,000	16,643,000	16,012,000	16,687,000	3,707,000	541,000	759,000	1,082,000	1,317,000	1,575,000	1,881,000	2,345,000	2,961,000	4,169,000	4,772,000	5,102,000	5,467,000	4,674,000	5,726,000	5,882,000	6,113,000	6,256,000	7,768,000	7,558,000	7,755,000	7,844,000	8,247,000	8,445,000	8,772,000	15,992,000	23,415,000	23,606,000	17,173,000	17,325,000	23,907,000	23,505,000	23,103,000	22,620,000	27,338,000	26,254,000	25,755,000	24,924,000	24,419,000	23,255,000	21,588,000	20,491,000	19,180,000	17,855,000	16,184,000	14,475,000	12,750,000	10,949,000	9,788,000	7,995,000	6,838,000	2,515,000	1,734,000	869,000	619,000
right-of-use assets and other						329,278,000	342,122,000	306,148,000	303,523,000	289,627,000	290,578,000
long-term portion of deferred revenues									6,724,000			6,491,000	7,209,000	8,035,000		9,444,000	8,577,000	9,760,000		9,322,000	15,003,000
retained earnings									11,186,000	5,803,000
total stockholders' equity									2,527,938,000	2,555,136,000		2,491,402,000	2,391,260,000	2,293,851,000
long-term portion of deferred revenue										6,299,000	6,582,000				8,739,000				3,755,000			14,133,000	6,596,000	15,399,000	16,632,000	8,323,000	15,897,000	2,268,000	11,970,000	3,177,000	238,520,000	246,092,000	253,663,000	261,236,000	237,094,000	232,573,000	180,838,000	184,431,000
other long-term assets												280,008,000	279,705,000	138,986,000	131,002,000	134,678,000	134,928,000	124,682,000	71,853,000	69,409,000	60,502,000	57,312,000	53,145,000	7,268,000	5,763,000	3,902,000	2,424,000	1,492,000	948,000	1,929,000	12,092,000	692,000	862,000	1,251,000	1,232,000	1,774,000	2,210,000	2,068,000	2,309,000
stockholders' equity
commitments
other receivables																								13,801,000	12,390,000	7,445,000	16,056,000																								2,751,000	2,708,000	2,284,000	1,930,000	30,190,000	4,654,000	6,363,000	5,771,000	5,896,000	7,306,000	6,028,000	7,090,000	11,864,000	9,594,000	8,860,000	3,712,000	1,457,000	1,820,000	6,504,000	9,190,000	6,087,000	8,256,000	2,855,000	3,812,000	22,197,000	3,511,000	1,391,000	5,936,000	7,102,000	6,671,000	4,512,000	13,142,000	4,424,000	5,090,000	2,477,000	3,556,000	2,844,000	4,145,000
long-term restricted cash and investments																								1,000,000	1,100,000	1,100,000	1,100,000	1,100,000	1,100,000	1,500,000	4,646,000	4,650,000	4,650,000	4,150,000	4,150,000	4,150,000	4,150,000	2,650,000	2,650,000	2,650,000	2,684,000	2,684,000	4,684,000	4,684,000	10,781,000	10,814,000	16,897,000	15,889,000	21,956,000	21,899,000	27,964,000
operating lease right-of-use assets																								17,735,000	16,573,000	13,921,000	5,867,000	5,989,000
long-term portion of lease liabilities																								23,705,000	22,543,000	19,958,000	12,178,000	12,619,000
preferred stock, 0.001 par value, 10,000,000 shares authorized and no shares issued
current portion of deferred revenue																									321,000	2,376,000			5,939,000		31,984,000	31,377,000	31,255,000	30,662,000	19,665,000	18,939,000	14,631,000	14,371,000
unbilled collaboration revenue																										7,244,000		24,489,000		31,844,000
short-term restricted cash and investments																												504,000	504,000	504,000	504,000										6,109,000	6,108,000	12,212,000	12,210,000	12,214,000	12,208,000	12,213,000	12,211,000	12,214,000	12,206,000	12,246,000	12,242,000
trade and other receivables																												104,634,000	167,161,000	91,999,000	81,192,000	90,005,000	43,125,000	34,076,000	42,246,000	91,207,000	17,799,000	10,088,000	5,183,000	3,470,000	3,758,000	3,882,000	4,882,000	4,722,000	5,034,000	4,457,000	3,941,000	5,171,000	4,209,000	3,865,000
financing obligation for build-to-suit lease																													20,646,000
convertible notes																																		113,349,000
term loan payable																																						80,000,000
stockholders’ equity
accrued collaboration liability																																				18,710,000	16,993,000	14,674,000	10,938,000
current portion of convertible notes																																			109,122,000	29,365,000	27,500,000	27,500,000		450,000		3,911,000	98,880,000	96,496,000	94,207,000		10,000,000	10,000,000	10,000,000	10,000,000	10,000,000
current portion of term loan payable																																			80,000,000	80,000,000	80,000,000
long-term portion of convertible notes																																				81,493,000	288,555,000	281,156,000	301,435,000	297,436,000	291,225,000	284,355,000	182,395,000	177,962,000	173,635,000	261,408,000	255,147,000	248,707,000	242,459,000	236,385,000	240,476,000
long-term portion of term loan payable
liabilities and stockholders’ deficit
other accrued liabilities																																				19,791,000	22,248,000	13,671,000	10,007,000	15,969,000	15,803,000	13,867,000	12,282,000	13,855,000	15,859,000	11,974,000	13,116,000	13,017,000	15,362,000	10,392,000	11,795,000	8,882,000	6,425,000	8,218,000	8,423,000	15,195,000	15,569,000	15,993,000	16,797,000	19,625,000	20,243,000	18,837,000	16,399,000	18,742,000	15,467,000	13,915,000	14,007,000				7,594,000	11,499,000	9,657,000		7,018,000
preferred stock
stockholders’ deficit:
total stockholders’ deficit																																					-186,134,000	-155,954,000	-104,304,000	-74,228,000	-188,188,000	-146,759,000															-81,815,000	-68,749,000	-228,325,000	-217,593,000	-214,694,000	-199,285,000	-163,725,000	-142,770,000	-123,619,000	-88,948,000
total liabilities and stockholders’ deficit																																					477,136,000	492,533,000	332,342,000	363,241,000	248,778,000	282,934,000															454,182,000	495,736,000	360,790,000		419,725,000	284,220,000	343,410,000	421,102,000	333,177,000	355,105,000
*
current portion of restructuring																																						3,017,000	3,205,000	3,734,000	5,294,000	4,993,000	6,426,000	6,580,000	3,726,000	4,298,000	4,425,000	3,776,000	4,194,000	4,077,000	5,085,000	4,033,000	4,484,000	3,875,000	4,483,000	2,725,000	2,624,000	3,850,000
long-term portion of restructuring																																						516,000	1,385,000	2,230,000	3,080,000	3,697,000	4,365,000	5,521,000	6,743,000	7,933,000	9,047,000	10,126,000	11,679,000	12,767,000	14,137,000	6,456,000	7,499,000	8,481,000	9,495,000	7,670,000	7,478,000	8,954,000
current portion of loans payable																																										164,000	381,000	757,000	1,077,000	1,392,000	1,762,000	2,127,000	2,546,000	2,858,000	3,170,000
deferred revenue																																										7,000	2,583,000	1,319,000	1,127,000	1,243,000	1,450,000	1,017,000	1,507,000	9,211,000	16,321,000	24,134,000	31,253,000	31,253,000	41,920,000	76,639,000	99,603,000	99,802,000	100,297,000	102,254,000	119,948,000	101,748,000	103,385,000	118,499,000	91,314,000	83,869,000	88,936,000	45,266,000	63,768,000	65,675,000	64,105,000	57,260,000	60,141,000	72,995,000	63,476,000	43,655,000	51,826,000	59,259,000	43,484,000	27,935,000	32,497,000	41,994,000	28,697,000	15,777,000	15,251,000	20,029,000	17,267,000	24,184,000
long-term portion of loans payable																																							80,000,000	80,000,000	80,000,000	80,000,000	80,000,000	80,000,000	80,055,000	80,219,000	80,328,000	80,757,000	81,132,000	81,611,000	82,090,000
revenues:
net product revenues																																							34,158,000
license and contract revenues																																							3,014,000
total revenues																																							37,172,000																				185,045,000
operating expenses:
cost of goods sold																																							3,895,000
research and development																																							96,351,000																				210,678,000
selling, general and administrative																																							57,305,000
restructuring charges																																							1,042,000
total operating expenses																																							158,593,000																				276,442,000
income from operations																																							-121,421,000																				-91,397,000
other income, net:
interest income and other																																							412,000																				138,000
interest expense																																							-48,673,000																				-9,340,000
total other income																																							-48,261,000																				-1,005,000
income before income taxes																																							-169,682,000
income tax benefit																																							55,000
net income																																							-169,737,000
net income per share																																							-810																				-850
shares used in computing basic and diluted net income per share amounts																																							209,227,000
other assets																																								6,508,000	7,197,000	7,771,000	8,340,000	7,101,000	8,022,000	8,918,000	6,888,000	7,300,000	7,713,000	8,125,000	8,538,000	9,123,000	2,797,000	2,905,000	2,789,000	2,896,000	4,122,000	4,214,000	4,096,000	4,540,000	4,449,000	2,586,000	2,427,000	7,695,000	8,000,000	8,168,000	8,336,000	8,666,000	8,970,000	1,947,000	2,004,000	2,071,000	2,003,000	1,586,000	1,695,000	1,838,000	2,685,000	2,964,000	3,303,000	3,679,000	4,175,000	4,617,000	3,953,000	4,164,000	4,304,000	3,900,000	3,753,000	3,984,000
liabilities and stockholders’ (deficit) equity
stockholders’ (deficit) equity:
total stockholders’ (deficit) equity																																											-114,829,000	-58,511,000
total liabilities and stockholders’ (deficit) equity																																											327,960,000	383,656,000
contingencies
restricted cash and investments																																																				27,946,000	4,067,000	4,199,000	4,199,000	4,199,000	4,199,000	4,199,000	6,399,000	6,399,000	6,399,000	6,444,000	6,444,000	4,744,000	4,744,000	4,853,000	4,015,000	4,854,000	5,694,000	5,333,000	7,238,000	8,078,000	8,917,000	9,908,000	9,635,000	11,221,000	11,004,000	12,123,000	12,682,000	13,522,000	14,753,000	15,480,000	16,040,000	16,390,000	7,635,000	5,137,000
current portion of notes payable and bank obligations																																																				3,164,000	3,158,000	4,015,000	4,870,000	5,974,000	7,628,000	8,064,000	8,848,000	9,005,000	9,772,000	9,919,000	11,204,000	11,459,000	12,689,000	13,919,000	14,911,000	16,945,000	17,770,000	14,942,000	15,767,000	12,527,000	12,628,000	13,521,000	13,579,000	11,527,000	11,544,000	12,081,000	11,893,000	9,691,000	9,162,000	8,016,000	8,928,000	7,177,000	5,405,000	4,658,000	4,658,000	3,174,000
current portion of convertible loans																																																				10,000,000	10,000,000	10,000,000		28,900,000	28,900,000	28,900,000	28,900,000	28,050,000	28,050,000	28,050,000	28,050,000	28,050,000	28,050,000	28,050,000	28,050,000
long-term portion of notes payable and bank obligations																																																				82,885,000	83,678,000	84,470,000	85,260,000	85,787,000	86,574,000	85,825,000
long-term portion of convertible loans																																																				239,244,000	85,862,000	83,578,000	91,385,000	89,295,000	87,288,000	85,240,000
183,489,026 and 135,563,735 shares at september 30, 2012 and december 31, 2011, respectively:																																																				183,000
148,794,245 and 135,563,735 shares at june 30, 2012 and december 31, 2011, respectively:																																																					149,000
148,457,650 and 135,563,735 shares at march 31, 2012 and december 31, 2011, respectively:																																																						148,000
135,563,735 and 109,287,160 shares at december 31, 2011 and 2010, respectively																																																							135,000
notes payable and bank obligations																																																											87,314,000		89,422,000	9,502,000	11,463,000	9,976,000	12,406,000	14,831,000	17,769,000	21,433,000	25,094,000	17,939,000	20,747,000	14,841,000	17,713,000	20,633,000	23,074,000	15,965,000	18,301,000	21,250,000	21,858,000	19,672,000	22,380,000	18,633,000	21,398,000	17,791,000	13,271,000	13,273,000	11,834,000	8,297,000
convertible loans																																																											83,396,000		108,900,000	28,900,000	28,900,000	56,950,000	56,950,000	56,950,000	56,950,000	85,000,000	85,000,000	85,000,000	85,000,000	85,000,000	85,000,000	85,000,000	85,000,000
contract																																																											61,271,000
license																																																											96,363,000
collaboration reimbursement																																																											27,411,000
general and administrative																																																											33,020,000
collaboration cost sharing
restructuring charge																																																											32,744,000
other income:
gain on sale of businesses																																																											8,197,000
loss on deconsolidation of symphony evolution, inc.
consolidated income before taxes																																																											-92,402,000
tax benefit																																																											72,000
consolidated net income																																																											-92,330,000
loss attributed to noncontrolling interest
net income attributable to exelixis, inc.																																																											-92,330,000
shares used in computing basic and diluted loss per share amounts																																																											108,522,000
liabilities, noncontrolling interest and stockholders’ deficit
long term portion of notes payable and bank obligations																																																												87,295,000
long term portion of convertible loans																																																												110,561,000
exelixis, inc. stockholders’ deficit:
total exelixis, inc. stockholders’ deficit																																																												-217,593,000	-214,694,000	-199,285,000	-163,725,000	-142,770,000	-123,619,000	-87,506,000
noncontrolling interest																																																																		-1,442,000
total liabilities, noncontrolling interest, and stockholders’ deficit																																																												372,906,000
liabilities, noncontrolling interest and stockholders’ equity
investments held by symphony evolution, inc.																																																																		12,581,000	14,703,000	18,473,000	22,376,000	27,573,000	30,935,000	38,731,000	44,709,000	50,952,000	55,087,000	59,740,000	65,036,000	30,279,000	34,039,000	37,542,000	40,005,000
long-term marketable securities																																																																9,976,000	12,406,000	14,831,000		21,434,000	25,094,000	17,939,000	20,747,000	13,516,000	15,537,000	17,553,000	19,573,000	11,768,000
noncontrolling interest in symphony evolution, inc.																																																																			714,000	3,510,000	6,191,000	9,534,000	13,430,000	15,838,000	24,022,000	31,482,000	38,071,000	44,934,000	50,480,000	20,234,000	23,752,000	28,643,000	33,729,000
total liabilities, noncontrolling interest and stockholders’ equity																																																																			401,622,000	254,763,000	316,621,000	370,572,000	412,120,000	420,291,000	371,788,000	420,631,000	395,417,000	270,657,000	306,477,000	337,582,000	332,712,000
other accrued expenses																																																																				4,827,000	7,303,000	5,562,000				7,127,000		13,613,000	13,001,000	13,060,000	13,774,000	11,419,000	10,489,000	9,460,000	12,012,000	9,085,000	10,371,000	11,867,000	9,675,000	9,125,000
other intangibles																																																																								328,000	2,461,000	2,533,000	2,605,000	2,704,000	2,914,000	3,154,000	3,425,000	3,697,000	3,968,000	4,240,000	4,512,000	3,690,000	3,858,000	3,969,000	4,302,000	4,469,000
current portion of capital lease obligations																																																																														8,000	98,000	347,000	731,000	1,357,000	1,931,000	2,177,000	2,679,000	3,408,000	5,552,000	6,432,000
convertible promissory note																																																																														30,000,000	30,000,000	30,000,000	30,000,000
convertible promissory loans																																																																												85,000,000	85,000,000			85,000,000	85,000,000
convertible promissory note and loans																																																																														85,000,000	85,000,000
capital lease obligations																																																																																		8,000	98,000	297,000	627,000	1,136,000	2,467,000	3,307,000
prepaid expense and other current assets																																																																																7,141,000	5,891,000	5,248,000
related-party receivables																																																																																7,000	9,000	24,000	51,000				540,000	600,000
convertible promissory note and loan																																																																																		115,000,000	115,000,000	85,000,000	85,000,000	85,000,000	55,000,000	55,000,000
notes receivable from stockholders
deferred stock compensation
other current assets																																																																																				6,532,000	5,116,000	3,780,000	4,834,000	5,452,000
restricted cash																																																																																							18,882,000	12,588,000

We provide you with 20 years of balance sheets for Exelixis stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Exelixis. Explore the full financial landscape of Exelixis stock with our expertly curated balance sheets.

The information provided in this report about Exelixis stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.